Press release
September 8, 2026
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
NRX Pharmaceuticals, Inc. (NRXP)
WILMINGTON, Del., Sept. 08, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that the management team will participate in three upcoming investor conferences in September 2026.